BIO Patient & Health Advocacy Summit

About the BIO Patient & Health Advocacy Summit

The BIO Patient and Health Advocacy Summit brings together patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders for two days of robust programming to discuss timely policy issues and share best practices. The Summit also provides invaluable networking opportunities to advance partnership among stakeholders in the healthcare ecosystem. The Summit convenes more than 320 attendees from over 200 organizations.

Save the date for the 2020 BIO Patient and Health Advocacy Summit!

October 25-26, 2020

Washington, DC.

View the 2019 Event Recap

#BIOSummit19 Concludes with Message of Hope Offered by Innovation

FDA Discusses Effective Patient Engagement at #BIOSummit19

View the 2019 Onsite Guide

The BIO Patient & Health Advocacy Summit is a very powerful intersection of pharma, biotech, and advocacy. The exchange of challenges, ideas, concerns, and opportunities at this BIO conferences is a very powerful force in refining the perspectives, thinking, and impacting future plans of those attending. The setting is modest in size allowing not just for superficial networking, rather there is time and space for in depth conversation and follow-up.

Dean Suhr

President, MLD Foundation

Blog Posts

Browse all Blogs

Is ICER Changing the Rules to Reach It’s Desired Outcome?

January 17, 2020

Jennifer Bright with the Innovation and Value Initiative recently wrote for Morning Consult that the U.S. is “engaged in the challenging but important conversation about how to assess the value of pharmaceuticals.” …

GAO Report Exposes New Weaknesses in 340B Drug Discount Program

January 16, 2020

The 340B Drug Discount Program is in the spotlight with the release of a new report from the Government Accountability Office (GAO) calling attention to oversight of the program designed to help vulnerable patients gain…

Veterans Are Under-Represented in Clinical Studies. NAVREF Is Working to Change That.

December 18, 2020

Rick Starrs, CEO of NAVREF When it comes to clinical research trials, America leads the world in providing patients with access to the latest, state-of-the-art care. However, an under-represented…